Table 2.
Univariate analyses examining the associations of CAP and VFA with anthropometries and clinical parameters
| Male |
Female |
All |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAP |
VFA |
CAP |
VFA |
CAP |
VFA |
|||||||
| r | p value | r | p value | r | p value | r | p value | r | p value | r | p value | |
| Age | 0.068 | 0.498 | 0.324 | 0.001 | –0.004 | 0.933 | 0.249 | <0.001 | –0.002 | 0.954 | 0.249 | <0.001 |
| BMI | 0.393 | <0.001 | 0.484 | <0.001 | 0.336 | <0.001 | 0.532 | <0.001 | 0.370 | <0.001 | 0.541 | <0.001 |
| WC | 0.372 | <0.001 | 0.512 | <0.001 | 0.350 | <0.001 | 0.525 | <0.001 | 0.396 | <0.001 | 0.577 | <0.001 |
| HC | 0.337 | <0.001 | 0.379 | <0.001 | 0.239 | <0.001 | 0.370 | <0.001 | 0.278 | <0.001 | 0.379 | <0.001 |
| SBP | 0.112 | 0.261 | 0.219 | 0.026 | 0.298 | <0.001 | 0.368 | <0.001 | 0.323 | <0.001 | 0.487 | <0.001 |
| DBP | 0.023 | 0.817 | 0.262 | 0.008 | 0.232 | <0.001 | 0.239 | <0.001 | 0.309 | <0.001 | 0.426 | <0.001 |
| ALT | 0.099 | 0.322 | 0.164 | 0.099 | 0.335 | <0.001 | 0.270 | <0.001 | 0.225 | <0.001 | 0.300 | <0.001 |
| AST | 0.073 | 0.463 | 0.184 | 0.065 | 0.310 | <0.001 | 0.271 | <0.001 | 0.334 | <0.001 | 0.322 | <0.001 |
| SCr | 0.188 | 0.057 | –0.017 | 0.868 | –0.040 | 0.388 | –0.144 | 0.014 | 0.308 | <0.001 | 0.319 | <0.001 |
| SUA | 0.045 | 0.650 | 0.055 | 0.584 | 0.288 | <0.001 | 0.150 | 0.001 | 0.111 | 0.008 | 0.136 | 0.001 |
| TC | 0.132 | 0.183 | 0.046 | 0.645 | 0.067 | 0.151 | 0.029 | 0.528 | 0.317 | <0.001 | 0.248 | <0.001 |
| TG | 0.095 | 0.338 | 0.064 | 0.521 | 0.226 | <0.001 | 0.213 | <0.001 | 0.058 | 0.171 | 0.011 | 0.787 |
| HDL-C | –0.115 | 0.249 | 0.043 | 0.665 | –0.150 | 0.001 | –0.179 | <0.001 | 0.233 | <0.001 | 0.254 | <0.001 |
| LDL-C | 0.144 | 0.146 | 0.083 | 0.402 | 0.097 | 0.036 | 0.051 | 0.275 | –0.182 | <0.001 | –0.203 | <0.001 |
| FBG | 0.027 | 0.786 | 0.275 | 0.005 | 0.270 | <0.001 | 0.328 | <0.001 | 0.082 | 0.051 | 0.030 | 0.479 |
| FINS | 0.315 | 0.001 | 0.451 | <0.001 | 0.321 | <0.001 | 0.340 | <0.001 | 0.242 | <0.001 | 0.337 | <0.001 |
| HOMA-IR | 0.245 | 0.013 | 0.474 | <0.001 | 0.284 | <0.001 | 0.363 | <0.001 | 0.343 | <0.001 | 0.384 | <0.001 |
| HbA1c | 0.035 | 0.725 | 0.202 | 0.042 | 0.284 | <0.001 | 0.363 | <0.001 | 0.361 | <0.001 | 0.435 | <0.001 |
| VFA | 0.382 | <0.001 | – | – | 0.351 | <0.001 | – | – | 0.259 | <0.001 | 0.366 | <0.001 |
| CAP | – | – | 0.382 | <0.001 | – | – | 0.429 | <0.001 | 0.463 | <0.001 | – | - |
BMI, body mass index; WC, waist circumference; HC, hip circumference; WHR, waist-to-hip ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; AST aspartate aminotransferase; ALT, alanine aminotransferase; SCr, serum creatinine; SUA, serum uric acid; TG, triglycerides; TC, total cholesterol; HDL, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; FBG, fasting plasma glucose; FINS, fasting insulin; HOMA-IR, homeostasis model assessment-insulin resistance; HbA1c, glycosylated hemoglobin A1c; VFA, visceral fat area; CAP, controlled attenuation parameter.